Outcomes of patients with multiple sclerosis at a neurorehabilitation unit in Saudi Arabia

References

1. ↵
   1. Rosati G

   (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22, 117–139.
2. ↵
   1. Pfleger CC,
   2. Flachs EM,
   3. Koch-Henriksen N

   (2010) Social consequences of multiple sclerosis (1): early pension and temporary unemployment--a historical prospective cohort study. Mult Scler 16, 121–126.
3. ↵
   1. Pfleger CC,
   2. Flachs EM,
   3. Koch-Henriksen N

   (2010) Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study. Mult Scler 16, 878–882.
4. ↵
   1. Frohman EM,
   2. Racke M,
   3. van Den Noort S

   (2000) To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes. Arch Neurol 57, 930–932.
5. ↵
   1. Weinshenker BG,
   2. Bass B,
   3. Rice GP,
   4. Noseworthy J,
   5. Carriere W,
   6. Baskerville J,
   7. et al.

   (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112, 1419–1428.
6. ↵
   1. Ryan M,
   2. Piascik P

   (2002) Providing pharmaceutical care to the multiple sclerosis patient. J Am Pharm Assoc (Wash) 42, 753–766.
7. ↵
   1. Dutta R,
   2. Trapp BD

   (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68, S22–31.
8. ↵
   1. Heydarpour P,
   2. Khoshkish S,
   3. Abtahi S,
   4. Moradi-Lakeh M,
   5. Sahraian MA

   (2015) Multiple sclerosis epidemiology in middle East and North Africa: a systematic review and meta-analysis. Neuroepidemiology 44, 232–244.
9. ↵
   1. Bohlega S,
   2. Inshasi J,
   3. Al Tahan AR,
   4. Madani AB,
   5. Qahtani H,
   6. Rieckmann P

   (2013) Multiple sclerosis in the Arabian Gulf countries: a consensus statement. J Neurol 260, 2959–2963.
10. ↵
    (2013) Multiple Sclerosis International Federation. Atlas of MS 2013, Available from: http://www.msif.org/wp-content/uploads/2014/09/Atlas-of-MS.pdf. [Accessed June 3 2017].
11. ↵
    1. Maghzi AH,
    2. Ghazavi H,
    3. Ahsan M,
    4. Etemadifar M,
    5. Mousavi S,
    6. Khorvash F,
    7. et al.

    (2010) Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler 16, 359–361.
12. ↵
    1. Daif AK,
    2. Al-Rajeh S,
    3. Awada A,
    4. Al Bunyan M,
    5. Ogunniyi A,
    6. AbdulJabar M,
    7. et al.

    (1998) Pattern of presentation of multiple sclerosis in Saudi Arabia: analysis based on clinical and paraclinical features. Eur Neurol 39, 182–186.
13. ↵
    1. Solari A,
    2. Filippini G,
    3. Gasco P,
    4. Colla L,
    5. Salmaggi A,
    6. La Mantia L,
    7. et al.

    (1999) Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 52, 57–62.
14. ↵
    1. Khan F,
    2. Turner-Stokes L,
    3. Ng L,
    4. Kilpatrick T

    (2007) Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev 2, CD006036.
15. 1. Freeman JA,
    2. Langdon DW,
    3. Hobart JC,
    4. Thompson AJ

    (1997) The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 42, 236–244.
16. ↵
    1. Freeman JA,
    2. Langdon DW,
    3. Hobart JC,
    4. Thompson AJ

    (1999) Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 52, 50–56.
17. ↵
    (2017) CARF International. Comprehensive Integrated Inpatient Rehabilitation Programs, Available from: http://www.carf.org/Programs/ProgramDescriptions/MED-Inpatient-Rehab-Hospital. [Accessed November 4 2017].
18. ↵
    1. Dodds TA,
    2. Martin DP,
    3. Stolov WC,
    4. Deyo RA

    (1993) A validation of the functional independence measurement and its performance among rehabilitation inpatients. Arch Phys Med Rehabil 74, 531–536.
19. ↵
    1. Hobart JC,
    2. Lamping DL,
    3. Freeman JA,
    4. Langdon DW,
    5. McLellan DL,
    6. Greenwood RJ,
    7. et al.

    (2001) Evidence-based measurement: which disability scale for neurologic rehabilitation? Neurology 57, 639–644.
20. ↵
    1. Tullman MJ

    (2013) Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care 19, S15–20.
21. ↵
    1. Tharakan JJ,
    2. Chand RP,
    3. Jacob PC

    (2005) Multiple sclerosis in Oman. Neurosciences (Riyadh) 10, 223–225.
22. ↵
    1. Yaqub BA,
    2. Daif AK

    (1988) Multiple sclerosis in Saudi Arabia. Neurology 38, 621–623.
23. ↵
    1. Brosseau L,
    2. Wolfson C

    (1994) The inter-rater reliability and construct validity of the Functional Independence Measure for multiple sclerosis subjects. Clin Rehabil 8, 107–115.
24. ↵
    1. Granger CV,
    2. Cotter AC,
    3. Hamilton BB,
    4. Fiedler RC,
    5. Hens MM

    (1990) Functional assessment scales: a study of persons with multiple sclerosis. Arch Phys Med Rehabil 71, 870–875.
25. ↵
    (1990) Data Management Service of the Uniform Data System for Medical Rehabilitation and the Center for Functional Assessment Research. Guide for use of the uniform data set for medical rehabilitation including the functional independence measure (version 3.1) (State University of New York, Buffalo (USA)).
26. ↵
    1. Konečný L,
    2. Pospíšil P,
    3. Dufek M,
    4. Drlíková L,
    5. Anbais FH,
    6. Erajhi AA,
    7. et al.

    (2007) Functional impairment in multiple sclerosis. Scripta Medica (Brno) 80, 225–232.
27. ↵
    1. Morley MA,
    2. Coots LA,
    3. Forgues AL,
    4. Gage BJ

    (2012) Inpatient rehabilitation utilization for Medicare beneficiaries with multiple sclerosis. Arch Phys Med Rehabil 93, 1377–1383.
28. ↵
    1. Gaber TA,
    2. Oo WW,
    3. Gautam V,
    4. Smith L

    (2012) Outcomes of inpatient rehabilitation of patients with multiple sclerosis. NeuroRehabilitation 30, 97–100.
29. ↵
    1. Kesselring J,
    2. Beer S

    (2005) Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 4, 643–652.
30. ↵
    1. Salhofer-Polanyi S,
    2. Windt J,
    3. Sumper H,
    4. Grill H,
    5. Essmeister M,
    6. Diermayr G,
    7. et al.

    (2013) Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis. NeuroRehabilitation 33, 285–292.
31. ↵
    1. Liberatore G,
    2. Clarelli F,
    3. Nuara A,
    4. Ungaro D,
    5. Gatti R,
    6. Rovaris M,
    7. et al.

    (2014) Predictors of effectiveness of multidisciplinary rehabilitation treatment on motor dysfunction in multiple sclerosis. Mult Scler 20, 862–870.